Strong balance sheet with cash, cash equivalents, and marketable securities of $208.9 million*, including proceeds from the equity financing, which is anticipated to close on January 13, 2026, and ...
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026 Phase ...
The £1.5 million farm, which has its own chief scientist, aims to produce 3,500 tons of insect protein a year using the black ...
A study reveals that many clinicians remain unaware of self-administered injectable contraception, despite its decades-long availability. Self-administered injectable contraceptives have been an ...
In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...
The Chosun Ilbo on MSN
Global pharma, Korean firms race in dementia drug development
U.S. pharmaceutical company Eli Lilly plans to disclose the topline results of its phase 3 clinical trial for remternemab, a new drug candidate developed as a successor to its Alzheimer’s treatment ...
This rate of weight regain is significantly faster than that seen in those who have lost weight by changing other lifestyle ...
Johnson & Johnson today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback